Search Results | Blood | American Society of Hematology

1-20 of 429

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences

Taylor Olmsted Kim, Amanda B. Grimes, Susan E. Kirk, Megan M. Gilbert, Helen D. Reed, Kristen A. Staggers, Lauryn A. Walker, Abinaya Arulselvan, A. Sarah Cohen, Michele P. Lambert, Jenny M. Despotovic

Blood (2020) 136 (5): 640–643.

DOI: https://doi.org/10.1182/blood.2020004888

Published: 2020

Includes: Supplemental data

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

DOI: https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-Fatigue) in Patients with Chronic Lymphocytic Leukemia (CLL)

Daniel Eek, PhD, Cristina Ivanescu, PhD, Leanne Kool-Houweling, MSc, David Cella, PhD

Blood (2019) 134 (Supplement_1): 4763.

DOI: https://doi.org/10.1182/blood-2019-123056

Published: 2019

Journal Articles

Improving Access to Healthcare for Pediatric Sickle Cell Disease Patients and Their Families

Maite E. Houwing, MD, Marit Buddenbaum, MA, LLM, Thijs C.J. Verheul, BSc, Anne P.J. de Pagter, MD PhD, Jan A Hazelzet, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2019) 134 (Supplement_1): 4835.

DOI: https://doi.org/10.1182/blood-2019-129892

Published: 2019

Journal Articles

Higher Rates of Death and Major Bleeding Highlight the Inequities That Exist in the Care of People with Venous Thromboembolism Who Experience Social Exclusion: Findings from a Prospective Registry of 79735 Patients (RIETE)

Karl Ewins, Fionnuala Ni Ainle, PhD, Cliona Ni Cheallaigh, MB BCH MRCPI PhD, Eoghan Dunlea, MB BCh MRCPI, Sarah Kelliher, MBBS, Egidio Imbalzano, MD, Cristiano Bortoluzzi, MD, Inés Jou, MD, Joaquín Alfonso-Megido, María del Carmen Díaz-Pedroche, Manuel Monreal, MD PhD

Blood (2019) 134 (Supplement_1): 4677.

DOI: https://doi.org/10.1182/blood-2019-130745

Published: 2019

Journal Articles

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Michael S Broder, MD MSHS, Qiufei Ma, PhD, Tingjian Yan, PhD, Eunice Chang, PhD, Lamis K. Eldjerou, MD, Yanni Hao, PhD, David Kuzan, MD, Jie Zhang, PhD

Blood (2019) 134 (Supplement_1): 4719.

DOI: https://doi.org/10.1182/blood-2019-122587

Published: 2019

Journal Articles

Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)

Lucie M Turcotte, MD, John A Whitton, MS, Wendy M. Leisenring, ScD, Todd Gibson, PhD, Rebecca M Howell, PhD, Kevin R. Krull, PhD, Joseph P. Neglia, MD MPH, Kevin C Oeffinger, MD, Kirsten K. Ness, PhD, William G. Woods, MD, E. Anders Kolb, MD, Leslie L. Robison, PhD, Gregory T Armstrong, MD, Eric J Chow, MD MPH

Blood (2019) 134 (Supplement_1): 1315.

DOI: https://doi.org/10.1182/blood-2019-123477

Published: 2019

Journal Articles

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Ellen K. Ritchie, MD, David Cella, PhD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH

Blood (2019) 134 (Supplement_1): 1332.

DOI: https://doi.org/10.1182/blood-2019-123779

Published: 2019

Journal Articles

Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors - a BMT Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, MS, Jessica Wu, MPH, Lindsey Hageman, MPH, Emily Ness, MPH, Michelle Kung, MA, Liton F. Francisco, BS, Alysia Bosworth, BA, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Wendy Landier, PhD CRNP, Merve - Pamukçuoğlu, MD, Saro H. Armenian, DO, MPH, Lennie Wong, PhD, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 699.

DOI: https://doi.org/10.1182/blood-2019-123344

Published: 2019

Journal Articles

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Blood (2019) 134 (Supplement_1): 635.

DOI: https://doi.org/10.1182/blood-2019-126128

Published: 2019

Journal Articles

Disparities in Healthcare Affordability Among Childhood Cancer Survivors Persist Following the Affordable Care Act

Mark A. Fiala, BS, Jin Huang, PhD, Mary E. Hartman, MD MPH

Blood (2019) 134 (Supplement_1): 2182.

DOI: https://doi.org/10.1182/blood-2019-131105

Published: 2019

Journal Articles

Value of Digital Patient Reported Outcomes (PROs) - Long-Term Management of Treatment Fatigue in Relapsed or Refractory Multiple Myeloma

Noa Biran, MD, Emre Yucel, PhD MSc, MBA, BSPharm, Robin Anthony Kouyaté, PhD, Gillian McGovern, MPH, Antoinette Schoenthaler, EdD, Olivia Durling, BS, Rashmi Unawane, MBBS, Andrew Schutt, MSc, Sumeet Panjabi, PhD

Blood (2019) 134 (Supplement_1): 3439.

DOI: https://doi.org/10.1182/blood-2019-123154

Published: 2019

Journal Articles

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD, Ralph Boccia, MD

Blood (2019) 134 (Supplement_1): 3445.

DOI: https://doi.org/10.1182/blood-2019-125793

Published: 2019

Journal Articles

A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy

Austin Kulasekararaj, MBBS MDMRCP FRCPath, Antonio M. Risitano, MD PhD, Jaroslaw P. Maciejewski, MD PhD, Rosario Notaro, MD, Peter Browett, BMedSci, MBChB, FRACP, FRCPA, Jong-Wook Lee, MD, Mingjun Huang, PhD, Michael Geffner, MD, Robert A. Brodsky, MD

Blood (2019) 134 (Supplement_1): 3514.

DOI: https://doi.org/10.1182/blood-2019-124748

Published: 2019

Journal Articles

High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN

Liping Li, MD PhD, Wenyan Lu, PhD, Alison R. Moliterno, MD, Lingling Xian, MD PhD, Joseph Kim, BS, Ophelia Rogers, Jerry L. Spivak, MD, Linda Resar, MD

Blood (2019) 134 (Supplement_1): 1680.

DOI: https://doi.org/10.1182/blood-2019-130262

Published: 2019

Journal Articles

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

Guillaume Carmona, PhD, Lauren Barney, PhD, Jared Sewell, PhD, Ryan Newman, Christine Carroll, Michael Beauregard, Janet Huang, MSc, Richard W Heidebrecht, Jr., PhD, Deya Corzo, MD, David Moller, MD, Devyn Smith, PhD, David Peritt, PhD, Rogerio Vivaldi, MD MBA

Blood (2019) 134 (Supplement_1): 2065.

DOI: https://doi.org/10.1182/blood-2019-127050

Published: 2019

Journal Articles

The Role of Medical Comorbidities and Socioeconomic Factors in the Prevalence of Venous Thromboembolism Among Different Ethnic/Racial Groups in a Hospitalized Population

Iberia R Sosa, MD, Courtney Nicole Miller-Chism, MD, Jason L Salemi, PhD

Blood (2019) 134 (Supplement_1): 2160.

DOI: https://doi.org/10.1182/blood-2019-129142

Published: 2019

Journal Articles

Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease

Wally R Smith, MD, Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Thokozeni Lipato, MD, Mica Ferlis, ANP, Caitlin Mcmanus, ANP, Margaret Guy, MD, Sarah Hartigan, MD, Emily Holt, BS, Chantal McHenry, BS, John D. Roberts, MD

Blood (2019) 134 (Supplement_1): 2104.

DOI: https://doi.org/10.1182/blood-2019-130441

Published: 2019

Journal Articles

Novel HLA Typing Method Identifies HLA Alleles Associated with Pediatric ITP

Taylor Olmsted Kim, MD, Michael Greenwood, MD, Todd Eagar, PhD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 1067.

DOI: https://doi.org/10.1182/blood-2019-129235

Published: 2019

Journal Articles

Validation of Instrument to Assess Hemophilia-Related Distress

Christine L. Kempton, MD MSc, Vaughn Barry, PhD MPH, Tyler W. Buckner, MD MSc, Janet Figueroa, MPH, Shanna Mattis, MPH, Mary Ellen Lynch, PhD, Mary E Stout, MD, Stephanie Whitten, Scott Gillespie, Courtney McCracken, PhD

Blood (2019) 134 (Supplement_1): 936.

DOI: https://doi.org/10.1182/blood-2019-122544

Published: 2019

2 3 4 5

NARROW

Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-Fatigue) in Patients with Chronic Lymphocytic Leukemia (CLL)

Improving Access to Healthcare for Pediatric Sickle Cell Disease Patients and Their Families

Higher Rates of Death and Major Bleeding Highlight the Inequities That Exist in the Care of People with Venous Thromboembolism Who Experience Social Exclusion: Findings from a Prospective Registry of 79735 Patients (RIETE)

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors - a BMT Survivor Study (BMTSS)

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Disparities in Healthcare Affordability Among Childhood Cancer Survivors Persist Following the Affordable Care Act

Value of Digital Patient Reported Outcomes (PROs) - Long-Term Management of Treatment Fatigue in Relapsed or Refractory Multiple Myeloma

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy

High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

The Role of Medical Comorbidities and Socioeconomic Factors in the Prevalence of Venous Thromboembolism Among Different Ethnic/Racial Groups in a Hospitalized Population

Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease

Novel HLA Typing Method Identifies HLA Alleles Associated with Pediatric ITP

Validation of Instrument to Assess Hemophilia-Related Distress

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only